Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Esco Lifesciences Group has acquired Allwin Medical Devices, a medical devices business in California, for $2B. Esco Lifesciences Group acquisitions expand healthcare M&A capabilities by adding Allwin’s medical device portfolio and supporting CA acquisitions in regulated care settings. Allwin Medical Devices acquisition strengthens Esco’s strategic acquisition strategy in the medical devices sector, with a focus on product breadth and commercial scale. The add on acquisition is an announced strategic acquisition by a strategic buyer, with deal size reported over $100M and terms referenced at $1.5B to $4B, positioning the deal as a bolt-on expansion within healthcare deals CA.
Source
Read full article on europeanbusinessmagazine.comvia GN - announces acquisition of · April 21, 2026
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026